Laekna Successfully Completes Phase I Trial Of Obesity Drug

MT NewswiresJan 12 20:50 ET

Laekna Doses All Subjects in LAE102 Phase I Trial

MT NewswiresDec 3, 2024 19:24 ET

Laekna Obesity Drug Begins Clinical Study

MT NewswiresNov 28, 2024 05:31 ET

Laekna Starts Investigational New Drug-Enabling Study for Muscle Weakness Pill

MT NewswiresNov 27, 2024 21:09 ET

Citic Securities Acting as Placing Agent for Laekna

Dow JonesNov 20, 2024 19:25 ET

Laekna to Use Placement Proceeds for R&D

Dow JonesNov 20, 2024 19:25 ET